124.42
price up icon0.61%   0.75
after-market Handel nachbörslich: 124.13 -0.29 -0.23%
loading
Schlusskurs vom Vortag:
$123.67
Offen:
$124.26
24-Stunden-Volumen:
10.28M
Relative Volume:
1.49
Marktkapitalisierung:
$216.47B
Einnahmen:
$43.11B
Nettoeinkommen (Verlust:
$13.98B
KGV:
15.59
EPS:
7.98
Netto-Cashflow:
$6.66B
1W Leistung:
-5.76%
1M Leistung:
-6.44%
6M Leistung:
+6.53%
1J Leistung:
+21.94%
1-Tages-Spanne:
Value
$121.60
$126.03
1-Wochen-Bereich:
Value
$119.77
$133.03
52-Wochen-Spanne:
Value
$99.92
$140.84

Abbott Laboratories Stock (ABT) Company Profile

Name
Firmenname
Abbott Laboratories
Name
Telefon
(224) 667-6100
Name
Adresse
100 ABBOTT PARK ROAD, ABBOTT PARK, IL
Name
Mitarbeiter
114,000
Name
Twitter
@AbbottNews
Name
Nächster Verdiensttermin
2025-07-17
Name
Neueste SEC-Einreichungen
Name
ABT's Discussions on Twitter

Vergleichen Sie ABT mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Medical Devices icon
ABT
Abbott Laboratories
124.42 229.71B 43.11B 13.98B 6.66B 7.98
Medical Devices icon
BSX
Boston Scientific Corp
103.78 154.35B 17.55B 2.03B 2.72B 1.37
Medical Devices icon
SYK
Stryker Corp
387.32 149.60B 23.22B 2.86B 3.58B 7.40
Medical Devices icon
MDT
Medtronic Plc
89.70 114.97B 33.54B 4.66B 5.19B 3.62
Medical Devices icon
EW
Edwards Lifesciences Corp
76.56 45.92B 5.54B 4.18B 623.10M 7.00

Abbott Laboratories Stock (ABT) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-07-18 Hochstufung Jefferies Hold → Buy
2025-06-16 Eingeleitet Leerink Partners Market Perform
2024-10-08 Eingeleitet Oppenheimer Outperform
2024-09-19 Eingeleitet Piper Sandler Overweight
2024-07-30 Herabstufung Edward Jones Buy → Hold
2024-05-30 Eingeleitet Goldman Buy
2023-07-21 Hochstufung Wolfe Research Underperform → Peer Perform
2023-05-30 Herabstufung Morgan Stanley Overweight → Equal-Weight
2023-04-20 Bestätigt Barclays Overweight
2023-04-20 Bestätigt Bernstein Outperform
2023-04-20 Bestätigt JP Morgan Overweight
2023-04-20 Bestätigt Raymond James Outperform
2023-04-20 Bestätigt UBS Buy
2023-04-20 Bestätigt Wolfe Research Underperform
2023-03-29 Eingeleitet UBS Buy
2022-10-26 Eingeleitet Mizuho Neutral
2022-10-18 Eingeleitet Barclays Overweight
2022-10-12 Eingeleitet Jefferies Hold
2022-07-06 Eingeleitet Wolfe Research Underperform
2022-03-02 Fortgesetzt BofA Securities Buy
2022-01-27 Bestätigt Credit Suisse Outperform
2022-01-27 Bestätigt Morgan Stanley Overweight
2022-01-27 Bestätigt Raymond James Outperform
2022-01-27 Bestätigt UBS Buy
2021-12-10 Eingeleitet RBC Capital Mkts Outperform
2021-10-27 Hochstufung Atlantic Equities Neutral → Overweight
2021-10-14 Eingeleitet Redburn Neutral
2021-05-25 Eingeleitet Barclays Overweight
2021-04-15 Eingeleitet Atlantic Equities Neutral
2021-01-28 Hochstufung BTIG Research Neutral → Buy
2020-09-11 Eingeleitet Wolfe Research Outperform
2020-06-01 Herabstufung Goldman Neutral → Sell
2020-03-05 Eingeleitet Citigroup Buy
2020-02-13 Eingeleitet Goldman Neutral
2020-02-06 Fortgesetzt BTIG Research Neutral
2020-01-02 Herabstufung Guggenheim Buy → Neutral
2019-06-13 Bestätigt BofA/Merrill Buy
2019-02-07 Bestätigt BofA/Merrill Buy
2019-01-02 Herabstufung Citigroup Neutral → Sell
2018-11-30 Hochstufung Goldman Neutral → Buy
2018-10-16 Eingeleitet Barclays Overweight
2018-06-27 Eingeleitet Bernstein Outperform
2018-01-30 Bestätigt Citigroup Neutral
2018-01-25 Bestätigt Stifel Buy
2018-01-25 Hochstufung William Blair Mkt Perform → Outperform
2018-01-03 Eingeleitet Evercore ISI Outperform
2018-01-02 Hochstufung JP Morgan Neutral → Overweight
2018-01-02 Hochstufung Morgan Stanley Equal-Weight → Overweight
2017-10-19 Bestätigt RBC Capital Mkts Outperform
2017-10-19 Bestätigt Stifel Buy
Alle ansehen

Abbott Laboratories Aktie (ABT) Neueste Nachrichten

pulisher
11:48 AM

Abbott Laboratories: Hold Rating Amid Mixed Performance and Sector Challenges - TipRanks

11:48 AM
pulisher
10:32 AM

Abbott Labs stock rating reiterated at Buy by UBS despite guidance cut - Investing.com India

10:32 AM
pulisher
09:43 AM

Abbott Laboratories (ABT): I Am Very Upset With Abbott,” Says Jim Cramer - MSN

09:43 AM
pulisher
Jul 20, 2025

Abbott Laboratories falls after setting Q3 outlook below consensus - MSN

Jul 20, 2025
pulisher
Jul 20, 2025

Abbott Laboratories Stock (ABT) Opinions on Q2 Earnings and Guidance Update - Quiver Quantitative

Jul 20, 2025
pulisher
Jul 20, 2025

Abbott Laboratories (NYSE:ABT) Q2 2025 Earnings Call Transcript - MSN

Jul 20, 2025
pulisher
Jul 20, 2025

Notable healthcare headlines for the week: Trump’s tariff threats, J&J, Abbott Laboratories and Sarepta in focus - MSN

Jul 20, 2025
pulisher
Jul 19, 2025

What analysts say about Abbott Laboratories stockFree Wealth Management Insights - Autocar Professional

Jul 19, 2025
pulisher
Jul 19, 2025

What drives Abbott Laboratories stock priceHigh-performance investment picks - jammulinksnews.com

Jul 19, 2025
pulisher
Jul 19, 2025

Is Abbott Laboratories (ABT) a Buy After the Earnings Selloff? - AInvest

Jul 19, 2025
pulisher
Jul 19, 2025

Abbott Drops After Lowering Top End of Full-Year Guidance - MSN

Jul 19, 2025
pulisher
Jul 19, 2025

Abbott Laboratories: A Medtech Titan Positioned for Growth in a Transformed Healthcare Landscape - AInvest

Jul 19, 2025
pulisher
Jul 19, 2025

Abbott Laboratories Second Quarter 2025 Earnings: EPS Beats Expectations - Yahoo Finance

Jul 19, 2025
pulisher
Jul 19, 2025

Abbott Laboratories Sheds Nearly 5% On A Rare Guidance Miss - MSN

Jul 19, 2025
pulisher
Jul 19, 2025

A Quick Look at Today's Ratings for Abbott Laboratories(ABT.US), With a Forecast Between $135 to $159 - 富途牛牛

Jul 19, 2025
pulisher
Jul 18, 2025

How Abbott Laboratories (ABT) Balances Innovation with Shareholder Payouts - MSN

Jul 18, 2025
pulisher
Jul 18, 2025

Abbott Laboratories Stock Analysis and ForecastRobust investment performance - jammulinksnews.com

Jul 18, 2025
pulisher
Jul 18, 2025

Abbott Laboratories Trading Volume Drops 27.57% to $24.28 Billion Ranking 25th - AInvest

Jul 18, 2025
pulisher
Jul 18, 2025

Why Abbott Laboratories Is a Q2 2025 Buy: Growth & Yield - MSN

Jul 18, 2025
pulisher
Jul 18, 2025

Netflix, Abbott Labs Lead Friday’s Market Cap Stock Movers By Investing.com - Investing.com South Africa

Jul 18, 2025
pulisher
Jul 18, 2025

Netflix, Abbott Labs Lead Friday’s Market Cap Stock Movers - Investing.com

Jul 18, 2025
pulisher
Jul 18, 2025

Abbott Laboratories (NYSE:ABT) Releases Mixed Earnings Report - FXDailyReport.Com

Jul 18, 2025
pulisher
Jul 18, 2025

Analysts defend Abbott Labs' stock after Thursday's 'too punitive' sell-off - CNBC

Jul 18, 2025
pulisher
Jul 18, 2025

Scott+Scott Attorneys at Law LLP Alerts Investors There Is an Ongoing Securities Class Action Against Reckitt Benckiser Group PLC (OTC: RBGLY) - GlobeNewswire Inc.

Jul 18, 2025
pulisher
Jul 18, 2025

Abbott Laboratories (ABT) Drops on Lower Full-Year Guidance - MSN

Jul 18, 2025
pulisher
Jul 18, 2025

Abbott upgraded to Buy at Jefferies despite underwhelming outlook - MSN

Jul 18, 2025
pulisher
Jul 18, 2025

Abbott Labs stock price target lowered to $155 at Citi on China diagnostics headwinds - Investing.com UK

Jul 18, 2025
pulisher
Jul 18, 2025

Abbott Upgraded by Jefferies as Stock Selloff Seen as Overreaction - MSN

Jul 18, 2025
pulisher
Jul 18, 2025

Abbott Laboratories (ABT) Stock: Q2 Beat Masks Challenges from COVID Test Decline, Tariffs, and China Pressure - CoinCentral

Jul 18, 2025
pulisher
Jul 18, 2025

Abbott Leaps on Recent Stock Fluctuations - Baystreet.ca

Jul 18, 2025
pulisher
Jul 18, 2025

Are Medical Stocks Lagging Abbott Laboratories (ABT) This Year? - Yahoo Finance

Jul 18, 2025
pulisher
Jul 18, 2025

Down 9.0% in 4 Weeks, Here's Why Abbott (ABT) Looks Ripe for a Turnaround - Yahoo Finance

Jul 18, 2025
pulisher
Jul 18, 2025

Buy Rating on Abbott Laboratories: Attractive Valuation Amid Growth Prospects and Market Overreaction - TipRanks

Jul 18, 2025
pulisher
Jul 18, 2025

These Analysts Revise Their Forecasts On Abbott Following Q2 Results - Benzinga

Jul 18, 2025
pulisher
Jul 18, 2025

Abbott Labs stock falls 8% as China headwinds prompt guidance cut - Investing.com Canada

Jul 18, 2025
pulisher
Jul 18, 2025

A Quick Look at Today's Ratings for Abbott Laboratories(ABT.US), With a Forecast Between $140 to $153 - 富途牛牛

Jul 18, 2025
pulisher
Jul 18, 2025

Abbott Laboratories: What's Behind The Q2 Earnings Slump? (NYSE:ABT) - Seeking Alpha

Jul 18, 2025
pulisher
Jul 18, 2025

Abbott Labs stock falls 8% as China headwinds prompt guidance cut By Investing.com - Investing.com South Africa

Jul 18, 2025
pulisher
Jul 18, 2025

Abbott upgraded after post-earnings selloff, hardware drag seen temporary - Investing.com

Jul 18, 2025
pulisher
Jul 18, 2025

Abbott upgraded after post-earnings selloff, hardware drag seen temporary By Investing.com - Investing.com Canada

Jul 18, 2025
pulisher
Jul 18, 2025

Abbott Labs stock price target lowered to $135 by Mizuho on guidance cut - Investing.com

Jul 18, 2025
pulisher
Jul 18, 2025

As new tariffs loom, United shrugs while Abbott braces for a hit - Crain's Chicago Business

Jul 18, 2025
pulisher
Jul 18, 2025

Abbott Labs stock rating upgraded by Jefferies on growth outlook - Investing.com India

Jul 18, 2025
pulisher
Jul 18, 2025

Abbott Laboratories (ABT) Q2 2025 Earnings Call Highlights: Strong Growth in Medical Devices ... - Yahoo Finance

Jul 18, 2025

Finanzdaten der Abbott Laboratories-Aktie (ABT)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
medical_devices BSX
$103.78
price up icon 0.14%
medical_devices SYK
$387.32
price down icon 0.53%
medical_devices MDT
$89.70
price up icon 0.10%
medical_devices EW
$76.56
price up icon 0.09%
$74.16
price down icon 2.37%
Kapitalisierung:     |  Volumen (24h):